Loading…

Effect of Prophylactic Antifungal Protocols on the Prognosis of Liver Transplantation: A Propensity Score Matching and Multistate Model Approach

Background. Whether routine antifungal prophylaxis decreases posttransplantation fungal infections in patients receiving orthotopic liver transplantation (OLT) remains unclear. This study aimed to determine the effectiveness of antifungal prophylaxis for patients receiving OLT. Patients and Methods....

Full description

Saved in:
Bibliographic Details
Published in:BioMed research international 2016-01, Vol.2016 (2016), p.1-7
Main Authors: Soong, Ruey-Shyang, Lee, Wei-Chen, Chou, Hong-Shiue, Wu, Ting-Jung, Lee, Chen-Fang, Cheng, Chih-Hsien, Wang, Yu-Chao, Huang, Ting-Shuo, Chen, Yi-Chan, Chan, Kun-Ming
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c532t-f9cbc131ccd3a556e497c69afc5d77164e521610f0d789f8737ab14f70835cfc3
cites cdi_FETCH-LOGICAL-c532t-f9cbc131ccd3a556e497c69afc5d77164e521610f0d789f8737ab14f70835cfc3
container_end_page 7
container_issue 2016
container_start_page 1
container_title BioMed research international
container_volume 2016
creator Soong, Ruey-Shyang
Lee, Wei-Chen
Chou, Hong-Shiue
Wu, Ting-Jung
Lee, Chen-Fang
Cheng, Chih-Hsien
Wang, Yu-Chao
Huang, Ting-Shuo
Chen, Yi-Chan
Chan, Kun-Ming
description Background. Whether routine antifungal prophylaxis decreases posttransplantation fungal infections in patients receiving orthotopic liver transplantation (OLT) remains unclear. This study aimed to determine the effectiveness of antifungal prophylaxis for patients receiving OLT. Patients and Methods. This is a retrospective analysis of a database at Chang Gung Memorial Hospital. We have been administering routine antibiotic and prophylactic antifungal regimens to recipients with high model for end-stage liver disease scores (>20) since 2009. After propensity score matching, 402 patients were enrolled. We conducted a multistate model to analyze the cumulative hazards, probability of fungal infections, and risk factors. Results. The cumulative hazards and transition probability of “transplantation to fungal infection” were lower in the prophylaxis group. The incidence rate of fungal infection after OLT decreased from 18.9% to 11.4% ( p = 0.052 ); overall mortality improved from 40.8% to 23.4% ( p < 0.001 ). In the “transplantation to fungal infection” transition, prophylaxis was significantly associated with reduced hazards for fungal infection (hazard ratio: 0.57, 95% confidence interval: 0.34–0.96, p = 0.033 ). Massive ascites, cadaver transplantation, and older age were significantly associated with higher risks for mortality. Conclusion. Prophylactic antifungal regimens in high-risk recipients might decrease the incidence of posttransplant fungal infections.
doi_str_mv 10.1155/2016/6212503
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5056236</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A520715389</galeid><sourcerecordid>A520715389</sourcerecordid><originalsourceid>FETCH-LOGICAL-c532t-f9cbc131ccd3a556e497c69afc5d77164e521610f0d789f8737ab14f70835cfc3</originalsourceid><addsrcrecordid>eNqNkk9vFCEYxidGY5vam2dD4sVE1_JngMFDk0nTqsk2mljPhGVgh2YWRmBq9lv4kcu461o9lQvk5ceTl-d9quolgu8RovQMQ8TOGEaYQvKkOsYE1QuGavT0cCbkqDpN6RaW1SAGBXteHWHOa44JPa5-XVprdAbBgq8xjP12UDo7DVqfnZ38Wg1zPQcdhgSCB7k3c2HtQ3JpfrV0dyaCm6h8Ggfls8ou-A-g_S1nfHJ5C77pEA24Vln3zq-B8h24nobsUqFLPXRmAO04xqB0_6J6ZtWQzOl-P6m-X13eXHxaLL98_HzRLheaEpwXVuiVRgRp3RFFKTO14JoJZTXtOEesNhQjhqCFHW-EbTjhaoVqy2FDqLaanFTnO91xWm1Mp43PUQ1yjG6j4lYG5eS_N971ch3uJIWUYcKKwJu9QAw_JpOy3LikzVBMMGFKEjWEY9FQgR6D0poIAUlBX_-H3oYp-uJEoXCZGasb-Jcq8zHSeRtKi3oWlS3FkCNKGlGodztKx5BSNPbwOwTlHB85x0fu41PwVw8dOcB_wlKAtzugTLFTP90j5UxhjFUPaNHUCJF7fg3W8A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1827236480</pqid></control><display><type>article</type><title>Effect of Prophylactic Antifungal Protocols on the Prognosis of Liver Transplantation: A Propensity Score Matching and Multistate Model Approach</title><source>Wiley Online Library Open Access</source><source>Publicly Available Content Database</source><creator>Soong, Ruey-Shyang ; Lee, Wei-Chen ; Chou, Hong-Shiue ; Wu, Ting-Jung ; Lee, Chen-Fang ; Cheng, Chih-Hsien ; Wang, Yu-Chao ; Huang, Ting-Shuo ; Chen, Yi-Chan ; Chan, Kun-Ming</creator><contributor>Kumar, Anand</contributor><creatorcontrib>Soong, Ruey-Shyang ; Lee, Wei-Chen ; Chou, Hong-Shiue ; Wu, Ting-Jung ; Lee, Chen-Fang ; Cheng, Chih-Hsien ; Wang, Yu-Chao ; Huang, Ting-Shuo ; Chen, Yi-Chan ; Chan, Kun-Ming ; Kumar, Anand</creatorcontrib><description>Background. Whether routine antifungal prophylaxis decreases posttransplantation fungal infections in patients receiving orthotopic liver transplantation (OLT) remains unclear. This study aimed to determine the effectiveness of antifungal prophylaxis for patients receiving OLT. Patients and Methods. This is a retrospective analysis of a database at Chang Gung Memorial Hospital. We have been administering routine antibiotic and prophylactic antifungal regimens to recipients with high model for end-stage liver disease scores (&gt;20) since 2009. After propensity score matching, 402 patients were enrolled. We conducted a multistate model to analyze the cumulative hazards, probability of fungal infections, and risk factors. Results. The cumulative hazards and transition probability of “transplantation to fungal infection” were lower in the prophylaxis group. The incidence rate of fungal infection after OLT decreased from 18.9% to 11.4% ( p = 0.052 ); overall mortality improved from 40.8% to 23.4% ( p &lt; 0.001 ). In the “transplantation to fungal infection” transition, prophylaxis was significantly associated with reduced hazards for fungal infection (hazard ratio: 0.57, 95% confidence interval: 0.34–0.96, p = 0.033 ). Massive ascites, cadaver transplantation, and older age were significantly associated with higher risks for mortality. Conclusion. Prophylactic antifungal regimens in high-risk recipients might decrease the incidence of posttransplant fungal infections.</description><identifier>ISSN: 2314-6133</identifier><identifier>EISSN: 2314-6141</identifier><identifier>DOI: 10.1155/2016/6212503</identifier><identifier>PMID: 27747235</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Aged ; Aged, 80 and over ; Analysis ; Antifungal agents ; Antifungal Agents - administration &amp; dosage ; Ascites ; Blood transfusions ; Catheters ; Data Interpretation, Statistical ; Disease prevention ; Female ; Fungal infections ; Health aspects ; Hepatitis B ; Hepatitis C ; Hospitals ; Humans ; Immunosuppressive agents ; Incidence ; Infection ; Liver ; Liver cancer ; Liver diseases ; Liver Transplantation - mortality ; Liver Transplantation - statistics &amp; numerical data ; Male ; Medical prognosis ; Medicine ; Middle Aged ; Mortality ; Multivariate Analysis ; Mycoses ; Mycoses - mortality ; Mycoses - prevention &amp; control ; Outcome Assessment (Health Care) - methods ; Premedication - mortality ; Premedication - statistics &amp; numerical data ; Prognosis ; Propensity Score ; Proportional Hazards Models ; Reproducibility of Results ; Retrospective Studies ; Risk Factors ; Sensitivity and Specificity ; Surgical techniques ; Survival Rate ; Transplantation ; Transplants &amp; implants ; Treatment Outcome ; Urine</subject><ispartof>BioMed research international, 2016-01, Vol.2016 (2016), p.1-7</ispartof><rights>Copyright © 2016 Yi-Chan Chen et al.</rights><rights>COPYRIGHT 2016 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2016 Yi-Chan Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2016 Yi-Chan Chen et al. 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c532t-f9cbc131ccd3a556e497c69afc5d77164e521610f0d789f8737ab14f70835cfc3</citedby><cites>FETCH-LOGICAL-c532t-f9cbc131ccd3a556e497c69afc5d77164e521610f0d789f8737ab14f70835cfc3</cites><orcidid>0000-0002-2932-6878 ; 0000-0001-7245-9505 ; 0000-0002-3110-1598</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1827236480/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1827236480?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,25744,27915,27916,37003,37004,44581,74887</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27747235$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Kumar, Anand</contributor><creatorcontrib>Soong, Ruey-Shyang</creatorcontrib><creatorcontrib>Lee, Wei-Chen</creatorcontrib><creatorcontrib>Chou, Hong-Shiue</creatorcontrib><creatorcontrib>Wu, Ting-Jung</creatorcontrib><creatorcontrib>Lee, Chen-Fang</creatorcontrib><creatorcontrib>Cheng, Chih-Hsien</creatorcontrib><creatorcontrib>Wang, Yu-Chao</creatorcontrib><creatorcontrib>Huang, Ting-Shuo</creatorcontrib><creatorcontrib>Chen, Yi-Chan</creatorcontrib><creatorcontrib>Chan, Kun-Ming</creatorcontrib><title>Effect of Prophylactic Antifungal Protocols on the Prognosis of Liver Transplantation: A Propensity Score Matching and Multistate Model Approach</title><title>BioMed research international</title><addtitle>Biomed Res Int</addtitle><description>Background. Whether routine antifungal prophylaxis decreases posttransplantation fungal infections in patients receiving orthotopic liver transplantation (OLT) remains unclear. This study aimed to determine the effectiveness of antifungal prophylaxis for patients receiving OLT. Patients and Methods. This is a retrospective analysis of a database at Chang Gung Memorial Hospital. We have been administering routine antibiotic and prophylactic antifungal regimens to recipients with high model for end-stage liver disease scores (&gt;20) since 2009. After propensity score matching, 402 patients were enrolled. We conducted a multistate model to analyze the cumulative hazards, probability of fungal infections, and risk factors. Results. The cumulative hazards and transition probability of “transplantation to fungal infection” were lower in the prophylaxis group. The incidence rate of fungal infection after OLT decreased from 18.9% to 11.4% ( p = 0.052 ); overall mortality improved from 40.8% to 23.4% ( p &lt; 0.001 ). In the “transplantation to fungal infection” transition, prophylaxis was significantly associated with reduced hazards for fungal infection (hazard ratio: 0.57, 95% confidence interval: 0.34–0.96, p = 0.033 ). Massive ascites, cadaver transplantation, and older age were significantly associated with higher risks for mortality. Conclusion. Prophylactic antifungal regimens in high-risk recipients might decrease the incidence of posttransplant fungal infections.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Analysis</subject><subject>Antifungal agents</subject><subject>Antifungal Agents - administration &amp; dosage</subject><subject>Ascites</subject><subject>Blood transfusions</subject><subject>Catheters</subject><subject>Data Interpretation, Statistical</subject><subject>Disease prevention</subject><subject>Female</subject><subject>Fungal infections</subject><subject>Health aspects</subject><subject>Hepatitis B</subject><subject>Hepatitis C</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Immunosuppressive agents</subject><subject>Incidence</subject><subject>Infection</subject><subject>Liver</subject><subject>Liver cancer</subject><subject>Liver diseases</subject><subject>Liver Transplantation - mortality</subject><subject>Liver Transplantation - statistics &amp; numerical data</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Medicine</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Multivariate Analysis</subject><subject>Mycoses</subject><subject>Mycoses - mortality</subject><subject>Mycoses - prevention &amp; control</subject><subject>Outcome Assessment (Health Care) - methods</subject><subject>Premedication - mortality</subject><subject>Premedication - statistics &amp; numerical data</subject><subject>Prognosis</subject><subject>Propensity Score</subject><subject>Proportional Hazards Models</subject><subject>Reproducibility of Results</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Sensitivity and Specificity</subject><subject>Surgical techniques</subject><subject>Survival Rate</subject><subject>Transplantation</subject><subject>Transplants &amp; implants</subject><subject>Treatment Outcome</subject><subject>Urine</subject><issn>2314-6133</issn><issn>2314-6141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqNkk9vFCEYxidGY5vam2dD4sVE1_JngMFDk0nTqsk2mljPhGVgh2YWRmBq9lv4kcu461o9lQvk5ceTl-d9quolgu8RovQMQ8TOGEaYQvKkOsYE1QuGavT0cCbkqDpN6RaW1SAGBXteHWHOa44JPa5-XVprdAbBgq8xjP12UDo7DVqfnZ38Wg1zPQcdhgSCB7k3c2HtQ3JpfrV0dyaCm6h8Ggfls8ou-A-g_S1nfHJ5C77pEA24Vln3zq-B8h24nobsUqFLPXRmAO04xqB0_6J6ZtWQzOl-P6m-X13eXHxaLL98_HzRLheaEpwXVuiVRgRp3RFFKTO14JoJZTXtOEesNhQjhqCFHW-EbTjhaoVqy2FDqLaanFTnO91xWm1Mp43PUQ1yjG6j4lYG5eS_N971ch3uJIWUYcKKwJu9QAw_JpOy3LikzVBMMGFKEjWEY9FQgR6D0poIAUlBX_-H3oYp-uJEoXCZGasb-Jcq8zHSeRtKi3oWlS3FkCNKGlGodztKx5BSNPbwOwTlHB85x0fu41PwVw8dOcB_wlKAtzugTLFTP90j5UxhjFUPaNHUCJF7fg3W8A</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Soong, Ruey-Shyang</creator><creator>Lee, Wei-Chen</creator><creator>Chou, Hong-Shiue</creator><creator>Wu, Ting-Jung</creator><creator>Lee, Chen-Fang</creator><creator>Cheng, Chih-Hsien</creator><creator>Wang, Yu-Chao</creator><creator>Huang, Ting-Shuo</creator><creator>Chen, Yi-Chan</creator><creator>Chan, Kun-Ming</creator><general>Hindawi Publishing Corporation</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2932-6878</orcidid><orcidid>https://orcid.org/0000-0001-7245-9505</orcidid><orcidid>https://orcid.org/0000-0002-3110-1598</orcidid></search><sort><creationdate>20160101</creationdate><title>Effect of Prophylactic Antifungal Protocols on the Prognosis of Liver Transplantation: A Propensity Score Matching and Multistate Model Approach</title><author>Soong, Ruey-Shyang ; Lee, Wei-Chen ; Chou, Hong-Shiue ; Wu, Ting-Jung ; Lee, Chen-Fang ; Cheng, Chih-Hsien ; Wang, Yu-Chao ; Huang, Ting-Shuo ; Chen, Yi-Chan ; Chan, Kun-Ming</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c532t-f9cbc131ccd3a556e497c69afc5d77164e521610f0d789f8737ab14f70835cfc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Analysis</topic><topic>Antifungal agents</topic><topic>Antifungal Agents - administration &amp; dosage</topic><topic>Ascites</topic><topic>Blood transfusions</topic><topic>Catheters</topic><topic>Data Interpretation, Statistical</topic><topic>Disease prevention</topic><topic>Female</topic><topic>Fungal infections</topic><topic>Health aspects</topic><topic>Hepatitis B</topic><topic>Hepatitis C</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Immunosuppressive agents</topic><topic>Incidence</topic><topic>Infection</topic><topic>Liver</topic><topic>Liver cancer</topic><topic>Liver diseases</topic><topic>Liver Transplantation - mortality</topic><topic>Liver Transplantation - statistics &amp; numerical data</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Medicine</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Multivariate Analysis</topic><topic>Mycoses</topic><topic>Mycoses - mortality</topic><topic>Mycoses - prevention &amp; control</topic><topic>Outcome Assessment (Health Care) - methods</topic><topic>Premedication - mortality</topic><topic>Premedication - statistics &amp; numerical data</topic><topic>Prognosis</topic><topic>Propensity Score</topic><topic>Proportional Hazards Models</topic><topic>Reproducibility of Results</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Sensitivity and Specificity</topic><topic>Surgical techniques</topic><topic>Survival Rate</topic><topic>Transplantation</topic><topic>Transplants &amp; implants</topic><topic>Treatment Outcome</topic><topic>Urine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Soong, Ruey-Shyang</creatorcontrib><creatorcontrib>Lee, Wei-Chen</creatorcontrib><creatorcontrib>Chou, Hong-Shiue</creatorcontrib><creatorcontrib>Wu, Ting-Jung</creatorcontrib><creatorcontrib>Lee, Chen-Fang</creatorcontrib><creatorcontrib>Cheng, Chih-Hsien</creatorcontrib><creatorcontrib>Wang, Yu-Chao</creatorcontrib><creatorcontrib>Huang, Ting-Shuo</creatorcontrib><creatorcontrib>Chen, Yi-Chan</creatorcontrib><creatorcontrib>Chan, Kun-Ming</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Middle East &amp; Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BioMed research international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Soong, Ruey-Shyang</au><au>Lee, Wei-Chen</au><au>Chou, Hong-Shiue</au><au>Wu, Ting-Jung</au><au>Lee, Chen-Fang</au><au>Cheng, Chih-Hsien</au><au>Wang, Yu-Chao</au><au>Huang, Ting-Shuo</au><au>Chen, Yi-Chan</au><au>Chan, Kun-Ming</au><au>Kumar, Anand</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of Prophylactic Antifungal Protocols on the Prognosis of Liver Transplantation: A Propensity Score Matching and Multistate Model Approach</atitle><jtitle>BioMed research international</jtitle><addtitle>Biomed Res Int</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>2016</volume><issue>2016</issue><spage>1</spage><epage>7</epage><pages>1-7</pages><issn>2314-6133</issn><eissn>2314-6141</eissn><abstract>Background. Whether routine antifungal prophylaxis decreases posttransplantation fungal infections in patients receiving orthotopic liver transplantation (OLT) remains unclear. This study aimed to determine the effectiveness of antifungal prophylaxis for patients receiving OLT. Patients and Methods. This is a retrospective analysis of a database at Chang Gung Memorial Hospital. We have been administering routine antibiotic and prophylactic antifungal regimens to recipients with high model for end-stage liver disease scores (&gt;20) since 2009. After propensity score matching, 402 patients were enrolled. We conducted a multistate model to analyze the cumulative hazards, probability of fungal infections, and risk factors. Results. The cumulative hazards and transition probability of “transplantation to fungal infection” were lower in the prophylaxis group. The incidence rate of fungal infection after OLT decreased from 18.9% to 11.4% ( p = 0.052 ); overall mortality improved from 40.8% to 23.4% ( p &lt; 0.001 ). In the “transplantation to fungal infection” transition, prophylaxis was significantly associated with reduced hazards for fungal infection (hazard ratio: 0.57, 95% confidence interval: 0.34–0.96, p = 0.033 ). Massive ascites, cadaver transplantation, and older age were significantly associated with higher risks for mortality. Conclusion. Prophylactic antifungal regimens in high-risk recipients might decrease the incidence of posttransplant fungal infections.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>27747235</pmid><doi>10.1155/2016/6212503</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-2932-6878</orcidid><orcidid>https://orcid.org/0000-0001-7245-9505</orcidid><orcidid>https://orcid.org/0000-0002-3110-1598</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2314-6133
ispartof BioMed research international, 2016-01, Vol.2016 (2016), p.1-7
issn 2314-6133
2314-6141
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5056236
source Wiley Online Library Open Access; Publicly Available Content Database
subjects Aged
Aged, 80 and over
Analysis
Antifungal agents
Antifungal Agents - administration & dosage
Ascites
Blood transfusions
Catheters
Data Interpretation, Statistical
Disease prevention
Female
Fungal infections
Health aspects
Hepatitis B
Hepatitis C
Hospitals
Humans
Immunosuppressive agents
Incidence
Infection
Liver
Liver cancer
Liver diseases
Liver Transplantation - mortality
Liver Transplantation - statistics & numerical data
Male
Medical prognosis
Medicine
Middle Aged
Mortality
Multivariate Analysis
Mycoses
Mycoses - mortality
Mycoses - prevention & control
Outcome Assessment (Health Care) - methods
Premedication - mortality
Premedication - statistics & numerical data
Prognosis
Propensity Score
Proportional Hazards Models
Reproducibility of Results
Retrospective Studies
Risk Factors
Sensitivity and Specificity
Surgical techniques
Survival Rate
Transplantation
Transplants & implants
Treatment Outcome
Urine
title Effect of Prophylactic Antifungal Protocols on the Prognosis of Liver Transplantation: A Propensity Score Matching and Multistate Model Approach
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T05%3A47%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20Prophylactic%20Antifungal%20Protocols%20on%20the%20Prognosis%20of%20Liver%20Transplantation:%20A%20Propensity%20Score%20Matching%20and%20Multistate%20Model%20Approach&rft.jtitle=BioMed%20research%20international&rft.au=Soong,%20Ruey-Shyang&rft.date=2016-01-01&rft.volume=2016&rft.issue=2016&rft.spage=1&rft.epage=7&rft.pages=1-7&rft.issn=2314-6133&rft.eissn=2314-6141&rft_id=info:doi/10.1155/2016/6212503&rft_dat=%3Cgale_pubme%3EA520715389%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c532t-f9cbc131ccd3a556e497c69afc5d77164e521610f0d789f8737ab14f70835cfc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1827236480&rft_id=info:pmid/27747235&rft_galeid=A520715389&rfr_iscdi=true